CYTOKINETICS, INCORPORATED — Net Income by Fiscal Year
28 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/3dd12761-1372-424d-83ff-1a12475baa70/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-785.0M | 2025-01-01 – 2025-12-31 | evidence 0001193125-26-076495 |
| FY 2024 | $-589.5M | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-029206 |
| FY 2023 | $-526.2M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-022256 |
| FY 2022 | $-389.0M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-005515 |
| FY 2021 | $-215.3M | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-007218 |
| FY 2020 | $-127.3M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-009467 |
| FY 2019 | $-121.7M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-008694 |
| FY 2018 | $-106.3M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-006580 |
| FY 2017 | $-127.8M | 2017-01-01 – 2017-12-31 | evidence 0001564590-18-004398 |
| FY 2016 | $16.5M | 2016-01-01 – 2016-12-31 | evidence 0001193125-17-071866 |
| FY 2015 | $-37.5M | 2015-01-01 – 2015-12-31 | evidence 0001193125-16-491656 |
| FY 2014 | $-14.6M | 2014-01-01 – 2014-12-31 | evidence 0001193125-15-081081 |
| FY 2013 | $-33.7M | 2013-01-01 – 2013-12-31 | evidence 0001193125-14-089045 |
| FY 2012 | $-461.5M | 1997-08-06 – 2013-03-31 | evidence 0001193125-13-207032 |
| FY 2011 | $-418.4M | 1997-08-05 – 2012-03-31 | evidence 0001193125-12-211525 |
| FY 2010 | $-49.3M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-111660 |
| FY 2009 | $24.5M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-111660 |
| FY 2008 | $-56.4M | 2008-01-01 – 2008-12-31 | evidence 0001193125-12-111660 |
| FY 2007 | $-48.9M | 2007-01-01 – 2007-12-31 | evidence 0001193125-12-111660 |
| FY 2006 | $-57.1M | 2006-01-01 – 2006-12-31 | evidence 0001193125-12-111660 |
| FY 2005 | $-42.3M | 2005-01-01 – 2005-12-31 | evidence 0001193125-12-111660 |
| FY 2004 | $-37.2M | 2004-01-01 – 2004-12-31 | evidence 0001193125-12-111660 |
| FY 2003 | $-32.7M | 2003-01-01 – 2003-12-31 | evidence 0001193125-12-111660 |
| FY 2002 | $-23.1M | 2002-01-01 – 2002-12-31 | evidence 0001193125-12-111660 |
| FY 2001 | $-15.9M | 2001-01-01 – 2001-12-31 | evidence 0001193125-12-111660 |
| FY 2000 | $-13.1M | 2000-01-01 – 2000-12-31 | evidence 0001193125-12-111660 |
| FY 1999 | $-7.3M | 1999-01-01 – 1999-12-31 | evidence 0001193125-12-111660 |
| FY 1998 | $-2.0M | 1997-08-05 – 1998-12-31 | evidence 0001193125-12-111660 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
CYTOKINETICS, INCORPORATED — all facts · Revenue · Operating Income